Clin2
NCT06834165Possibly a fitRecruiting

Study of neffy vs. epinephrine shots for allergic reactions

Allergic Reactions

Treatments studied

Part of Immune system & allergy clinical trials.

This study compares a new nasal spray (neffy) to a standard epinephrine shot for treating severe allergic reactions during food challenges or allergy immunotherapy. It aims to see if the spray works as well and is safe.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
600 people
Ages
4 years and older
Study type
Interventional

Who can take part

  • Be 4 years old or older.
  • Weigh at least 33 pounds (15 kg).
  • Be scheduled for a food challenge, allergy shot, or similar allergy test.
  • Have a severe allergic reaction that needs epinephrine treatment.
  • Not have a medical condition that makes epinephrine unsafe for you.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07228325Enrolling by invitation· Phase 1/Phase 2
Comparing a new epinephrine injector to EpiPen in adults with allergies

This study tests a new epinephrine auto-injector (FMXIN002) compared to the standard EpiPen in people with a history of hay fever or seasonal allergies. The goal is to see if the new device works just as well and is safe in a controlled clinic setting.

Mississauga
NCT07038746Recruiting· Phase 1
Inhaled epinephrine for severe allergic reactions during tests or treatment

This trial tests if inhaled epinephrine can safely treat moderate to severe allergic reactions (grade 2 or higher) that can happen during allergy skin tests, oral food or drug challenges, or allergy shots. It is for people who have had such reactions in the past or are at risk and are planning to undergo one of these procedures.

Richmond, British Columbia
NCT07045701Enrolling by invitation· Phase 2/Phase 3
Testing FMXIN002 for food allergy reactions

This study is testing a new medicine (FMXIN002) for people who are at risk of a severe allergic reaction to food. If you have a known food allergy and have had a moderate reaction during a food challenge, you may be able to join. The trial will check if the medicine helps prevent or reduce the severity of future reactions.

Be’er Ya‘aqov
NCT06272409Not yet recruiting· Phase 3
Testing a new nasal spray for children with nasal allergies

This study tests a new nasal spray (DEP114) to see if it helps control moderate to severe allergic rhinitis symptoms in children. It compares the spray to a standard steroid nasal spray.

NCT07341776Recruiting· Phase 4
Testing steroids for food allergy reactions

This trial tests whether using a steroid drug can help treat allergic reactions to food. If you have a food allergy that causes immediate symptoms (like hives or trouble breathing), this study may help find better ways to manage those reactions.

Basel, Basel
NCT04163562Recruiting· Phase 1/Phase 2
Oral peanut treatment trial for people with peanut allergy

This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.

Pamplona, Navarre

Hear when a new Allergic Reactions trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.